Home > Cashflow Statement > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
Cash Flow from Financing Activities

    Back to Cashflow Statement
NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATH BIOGENES (INDIA)
Please provide your vote to see the results

NATH BIOGENES (INDIA) Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2013
Cash Flow from Financing Activities ₹-2.13 Cr₹-7.78 Cr₹-1.67 Cr₹-22 Cr₹5.74 Cr

What is the latest Cash Flow from Financing Activities ratio of NATH BIOGENES (INDIA) ?

The latest Cash Flow from Financing Activities ratio of NATH BIOGENES (INDIA) is ₹-2.13 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Financing Activities
Mar2025₹-2.13 Cr
Mar2024₹-7.78 Cr
Mar2023₹-1.67 Cr
Mar2022₹-22 Cr
Mar2013₹5.74 Cr

How is Cash Flow from Financing Activities of NATH BIOGENES (INDIA) Trending?

Years Cash Flow from Financing Activities % Change
Mar2025 ₹-2.13 Cr
Negative
Mar2024 ₹-7.78 Cr
Negative
Mar2023 ₹-1.67 Cr
Negative
Mar2022 ₹-22 Cr
Negative
Mar2013 ₹5.74 Cr -

Compare Cash Flow from Financing Activities of peers of NATH BIOGENES (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA) ₹294.0 Cr 8% -6% -25.6% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹13,043.2 Cr 3.1% -0.3% -21.8% Stock Analytics
KAVERI SEED COMPANY ₹4,978.0 Cr 2% -9.4% 2.9% Stock Analytics
VENKYS (INDIA) ₹2,003.9 Cr 4.8% 5.4% -20.8% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹1,032.3 Cr 0.2% -16.1% -39.6% Stock Analytics
INDO US BIOTECH ₹250.9 Cr -2.5% -3.8% -55.7% Stock Analytics


NATH BIOGENES (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA)

8%

-6%

-25.6%

SENSEX

-0.5%

1%

4.6%


You may also like the below Video Courses